The abstract is read at the publisher; the summary is JClub's.
METTL8 is a key m³C methyltransferase that regulates TFH differentiation, with METTL8 deficiency impairing TFH and germinal center responses in lymphocytic choriomeningitis virus infection and tumor models.
- Why it matters: TFH cell fate controls humoral immunity and is linked to immunotherapy outcomes, yet the epitranscriptomic mechanisms shaping TFH differentiation—especially during infection and checkpoint blockade—remain unclear.
- What they did: METTL8 was preferentially expressed in CXCL13hi TFH cells; its loss reduced TFH differentiation and germinal center responses in lymphocytic choriomeningitis virus infection and after anti-PD-1 in tumor models. Mechanistically, METTL8 stabilized Tcf7 mRNA via m³C modification and, via TCF1, regulated chromatin accessibility and 3D genome organization at TFH loci including Cxcr5 and Il6ra.
- The result: Ginkgolic acid suppressed TFH responses without compromising anti-PD-1 antitumor efficacy, and the effect was associated with METTL8, suggesting this pathway can tune TFH-driven immune responses.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.